View EO 12866 Meeting 0910-AI31

Title: Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

Agency/Subagency: 0910-HHS/FDA

Stage of Rulemaking: Proposed Rule Stage

Meeting Date/Time: 09/28/2023 11:30 AM

Requestor: Outsourcing Facilities Association Requestor's Name: Marc Wagner

Documents:

List of Documents
OFA _RIN 0910-AI31

Attendees:

List of Attendees		Participation
•	Jean McCue - FDA	Teleconference
•	Julie Wise - OMB	Teleconference
•	Joanne Davenport - OMB	Teleconference
•	Elizabeth Ashley - OMB	Teleconference
•	Jane Wargo - HHS	Teleconference
•	Kathleen Anderson - FDA	Teleconference
•	Aaron Young - FDA	Teleconference
•	Emily Galloway - FDA	Teleconference
•	Gabrielle Cosel - FDA	Teleconference
•	Nnaemeka Chukwudebe - FDA	Teleconference
•	Nicholas Beshara - FDA	Teleconference
•	Ian Reynolds - FDA	Teleconference
•	Marc Wagner - Outsourcing Facilities Association	In Person
•	Adam Higgins - BakerHostetler (on behalf of Outsourcing Facilities Association)	In Person
•	Lee Rosebush - Outsourcing Facilities Association	In Person